

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | organic cation transport (GO:0015695) | 4.07973714 |
| 2 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.77693391 |
| 3 | negative regulation of cell killing (GO:0031342) | 3.68830780 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.68830780 |
| 5 | response to interleukin-15 (GO:0070672) | 3.65188744 |
| 6 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.62462750 |
| 7 | microtubule nucleation (GO:0007020) | 3.54594542 |
| 8 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.54338233 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38667304 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 3.30439511 |
| 11 | germinal center formation (GO:0002467) | 3.27353924 |
| 12 | T cell migration (GO:0072678) | 3.11564254 |
| 13 | histone H3-K9 modification (GO:0061647) | 3.09615667 |
| 14 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 3.09152921 |
| 15 | amino acid salvage (GO:0043102) | 3.06295473 |
| 16 | L-methionine salvage (GO:0071267) | 3.06295473 |
| 17 | L-methionine biosynthetic process (GO:0071265) | 3.06295473 |
| 18 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.03360163 |
| 19 | male meiosis I (GO:0007141) | 3.00317039 |
| 20 | mannosylation (GO:0097502) | 2.99173143 |
| 21 | piRNA metabolic process (GO:0034587) | 2.99030049 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.98233370 |
| 23 | histone H3-K9 methylation (GO:0051567) | 2.97143085 |
| 24 | positive regulation of interleukin-2 production (GO:0032743) | 2.95787176 |
| 25 | tolerance induction (GO:0002507) | 2.94401623 |
| 26 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.94347107 |
| 27 | regulation of defense response to virus by host (GO:0050691) | 2.92925017 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92190232 |
| 29 | toxin transport (GO:1901998) | 2.85899066 |
| 30 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.84955220 |
| 31 | positive regulation of defense response to virus by host (GO:0002230) | 2.84140856 |
| 32 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.83527022 |
| 33 | rRNA catabolic process (GO:0016075) | 2.83012055 |
| 34 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.76669000 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.74847180 |
| 36 | response to lipoprotein particle (GO:0055094) | 2.73291613 |
| 37 | amyloid precursor protein catabolic process (GO:0042987) | 2.72720444 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.72416498 |
| 39 | response to muramyl dipeptide (GO:0032495) | 2.71480691 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 2.65973261 |
| 41 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.65049497 |
| 42 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.64988173 |
| 43 | synaptonemal complex assembly (GO:0007130) | 2.64435197 |
| 44 | positive regulation of protein homooligomerization (GO:0032464) | 2.64102557 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.63699980 |
| 46 | positive regulation of DNA recombination (GO:0045911) | 2.61880948 |
| 47 | snRNA processing (GO:0016180) | 2.60935498 |
| 48 | response to type I interferon (GO:0034340) | 2.60039930 |
| 49 | meiosis I (GO:0007127) | 2.59452046 |
| 50 | histone H3-K4 trimethylation (GO:0080182) | 2.59430083 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58966670 |
| 52 | pyrimidine dimer repair (GO:0006290) | 2.58434186 |
| 53 | positive regulation of isotype switching (GO:0045830) | 2.57021455 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56568609 |
| 55 | RNA destabilization (GO:0050779) | 2.55555972 |
| 56 | type I interferon signaling pathway (GO:0060337) | 2.55468931 |
| 57 | cellular response to type I interferon (GO:0071357) | 2.55468931 |
| 58 | DNA methylation involved in gamete generation (GO:0043046) | 2.54731534 |
| 59 | regulation of gamma-delta T cell activation (GO:0046643) | 2.50870636 |
| 60 | cellular response to exogenous dsRNA (GO:0071360) | 2.48679457 |
| 61 | positive regulation of mitochondrial fission (GO:0090141) | 2.48453508 |
| 62 | labyrinthine layer development (GO:0060711) | 2.47818038 |
| 63 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.47729195 |
| 64 | regulation of germinal center formation (GO:0002634) | 2.47152418 |
| 65 | N-acetylneuraminate metabolic process (GO:0006054) | 2.46987809 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.46064253 |
| 67 | protein K11-linked deubiquitination (GO:0035871) | 2.44759598 |
| 68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.44381326 |
| 69 | snRNA metabolic process (GO:0016073) | 2.43404599 |
| 70 | positive regulation of interleukin-4 production (GO:0032753) | 2.42555816 |
| 71 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.41816583 |
| 72 | negative regulation of T cell apoptotic process (GO:0070233) | 2.41726311 |
| 73 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.41426204 |
| 74 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.40189721 |
| 75 | erythrocyte development (GO:0048821) | 2.39228466 |
| 76 | synaptonemal complex organization (GO:0070193) | 2.37883770 |
| 77 | meiotic chromosome segregation (GO:0045132) | 2.37285737 |
| 78 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.36948125 |
| 79 | positive regulation of digestive system process (GO:0060456) | 2.36661721 |
| 80 | defense response to protozoan (GO:0042832) | 2.36411898 |
| 81 | negative regulation of interleukin-8 production (GO:0032717) | 2.36284307 |
| 82 | positive regulation of interferon-beta production (GO:0032728) | 2.35946091 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 2.35596827 |
| 84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.33637579 |
| 85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.33461695 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33365487 |
| 87 | organelle membrane fusion (GO:0090174) | 2.32962133 |
| 88 | regulation of hypersensitivity (GO:0002883) | 2.32627000 |
| 89 | regulation of cilium movement (GO:0003352) | 2.32599330 |
| 90 | regulation of T-helper cell differentiation (GO:0045622) | 2.32434692 |
| 91 | protein targeting to Golgi (GO:0000042) | 2.31484063 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.31250988 |
| 93 | interferon-gamma production (GO:0032609) | 2.30750079 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.29417881 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.28487658 |
| 96 | regulation of interferon-beta production (GO:0032648) | 2.27536896 |
| 97 | base-excision repair, AP site formation (GO:0006285) | 2.26608572 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.26460938 |
| 99 | positive regulation of humoral immune response (GO:0002922) | 2.26182995 |
| 100 | macroautophagy (GO:0016236) | 2.26145371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.90686494 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.55864251 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48025526 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.09532506 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.08185773 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.07211596 |
| 7 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.98948350 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.97481364 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.88097885 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.68799024 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.68737952 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57974295 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.41124078 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41010618 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.38470346 |
| 16 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.17174014 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.06630555 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06359220 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03095836 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.01059362 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99319987 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97471405 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.96911635 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 1.93551952 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91170275 |
| 26 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90218685 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85335921 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.84768966 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.80068812 |
| 30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78386020 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.76469404 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76171146 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.74090634 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.72918155 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70307395 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69309092 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65801531 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64473577 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64094689 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63221481 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61518993 |
| 42 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.61012051 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60638059 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60638027 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54740745 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50362457 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47665113 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.47015557 |
| 49 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.46937139 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46334844 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43050273 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40973047 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40683552 |
| 54 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.39086678 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38434285 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38375923 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.37938596 |
| 58 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.33309379 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.33090299 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30291146 |
| 61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.29437602 |
| 62 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29098904 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24259103 |
| 64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22196063 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22167500 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21862143 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21258680 |
| 68 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.18985298 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16853774 |
| 70 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.16032356 |
| 71 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14906813 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14832474 |
| 73 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13496067 |
| 74 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.09875591 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09480059 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08023176 |
| 77 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06549778 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06549453 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06135527 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04638583 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98591642 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98549960 |
| 83 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98241486 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97838349 |
| 85 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97315655 |
| 86 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93862295 |
| 87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93834746 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93635773 |
| 89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92062114 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91835697 |
| 91 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90958121 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89952457 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89232420 |
| 94 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.89211408 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89160574 |
| 96 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.89127108 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89047268 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89040196 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87974339 |
| 100 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87091125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 3.21798797 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.01697055 |
| 3 | MP0003436_decreased_susceptibility_to | 3.01340122 |
| 4 | MP0005671_abnormal_response_to | 2.92771792 |
| 5 | MP0003787_abnormal_imprinting | 2.77860004 |
| 6 | MP0009785_altered_susceptibility_to | 2.38387399 |
| 7 | MP0003303_peritoneal_inflammation | 2.33658990 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.33566734 |
| 9 | MP0009764_decreased_sensitivity_to | 2.31795906 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.28551931 |
| 11 | MP0001764_abnormal_homeostasis | 2.24564471 |
| 12 | MP0003724_increased_susceptibility_to | 2.23153054 |
| 13 | MP0006082_CNS_inflammation | 2.19117518 |
| 14 | MP0001800_abnormal_humoral_immune | 2.18010700 |
| 15 | MP0002723_abnormal_immune_serum | 2.16371501 |
| 16 | MP0002102_abnormal_ear_morphology | 2.04999711 |
| 17 | MP0005025_abnormal_response_to | 1.95028331 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 1.88765952 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.87648500 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.87135058 |
| 21 | MP0005310_abnormal_salivary_gland | 1.86660878 |
| 22 | MP0001819_abnormal_immune_cell | 1.86440053 |
| 23 | MP0008058_abnormal_DNA_repair | 1.85364010 |
| 24 | MP0002419_abnormal_innate_immunity | 1.84736264 |
| 25 | MP0009840_abnormal_foam_cell | 1.82796236 |
| 26 | MP0002132_abnormal_respiratory_system | 1.81591515 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.77581114 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.76188271 |
| 29 | MP0003718_maternal_effect | 1.75410321 |
| 30 | MP0003646_muscle_fatigue | 1.74099035 |
| 31 | MP0009278_abnormal_bone_marrow | 1.72402891 |
| 32 | MP0000685_abnormal_immune_system | 1.70690558 |
| 33 | MP0005410_abnormal_fertilization | 1.69052719 |
| 34 | MP0002398_abnormal_bone_marrow | 1.65710381 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.65630940 |
| 36 | MP0003011_delayed_dark_adaptation | 1.63261291 |
| 37 | MP0000716_abnormal_immune_system | 1.62023069 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.59386289 |
| 39 | MP0005499_abnormal_olfactory_system | 1.55446077 |
| 40 | MP0005394_taste/olfaction_phenotype | 1.55446077 |
| 41 | MP0002405_respiratory_system_inflammati | 1.54008410 |
| 42 | MP0003880_abnormal_central_pattern | 1.52749667 |
| 43 | MP0005387_immune_system_phenotype | 1.51956892 |
| 44 | MP0001790_abnormal_immune_system | 1.51956892 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.51447282 |
| 46 | MP0004484_altered_response_of | 1.51243603 |
| 47 | MP0002722_abnormal_immune_system | 1.50006100 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.49178597 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.47459986 |
| 50 | MP0008789_abnormal_olfactory_epithelium | 1.47012327 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.41935840 |
| 52 | MP0006276_abnormal_autonomic_nervous | 1.33948607 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.33675164 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.31217477 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.29073485 |
| 56 | MP0002429_abnormal_blood_cell | 1.26284402 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.24778392 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.20250037 |
| 59 | MP0005647_abnormal_sex_gland | 1.19247623 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.18757878 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.18552426 |
| 62 | MP0004233_abnormal_muscle_weight | 1.18372470 |
| 63 | MP0005365_abnormal_bile_salt | 1.12973364 |
| 64 | MP0005376_homeostasis/metabolism_phenot | 1.12042451 |
| 65 | MP0005085_abnormal_gallbladder_physiolo | 1.11136520 |
| 66 | MP0008469_abnormal_protein_level | 1.09823448 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.08214519 |
| 68 | MP0004947_skin_inflammation | 1.05715617 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.04449424 |
| 70 | MP0003959_abnormal_lean_body | 0.99803554 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.99138413 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.95543476 |
| 73 | MP0005266_abnormal_metabolism | 0.94639451 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.93774577 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 0.92321446 |
| 76 | MP0004142_abnormal_muscle_tone | 0.92285101 |
| 77 | MP0003698_abnormal_male_reproductive | 0.92253729 |
| 78 | MP0001929_abnormal_gametogenesis | 0.92021379 |
| 79 | MP0002928_abnormal_bile_duct | 0.91938609 |
| 80 | MP0003252_abnormal_bile_duct | 0.91725308 |
| 81 | MP0004883_abnormal_blood_vessel | 0.90738998 |
| 82 | MP0005253_abnormal_eye_physiology | 0.90490875 |
| 83 | MP0005423_abnormal_somatic_nervous | 0.86798170 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85966478 |
| 85 | MP0005395_other_phenotype | 0.84386342 |
| 86 | MP0001545_abnormal_hematopoietic_system | 0.81703537 |
| 87 | MP0005397_hematopoietic_system_phenotyp | 0.81703537 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.80903911 |
| 89 | MP0000343_altered_response_to | 0.80734850 |
| 90 | MP0003121_genomic_imprinting | 0.78138045 |
| 91 | MP0009697_abnormal_copulation | 0.75320619 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.75296111 |
| 93 | MP0002139_abnormal_hepatobiliary_system | 0.73459060 |
| 94 | MP0002210_abnormal_sex_determination | 0.69110111 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.67650761 |
| 96 | MP0000609_abnormal_liver_physiology | 0.67189901 |
| 97 | MP0005166_decreased_susceptibility_to | 0.66423861 |
| 98 | MP0001873_stomach_inflammation | 0.65403562 |
| 99 | MP0000249_abnormal_blood_vessel | 0.64802982 |
| 100 | MP0009763_increased_sensitivity_to | 0.64597640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 4.20683209 |
| 2 | Severe visual impairment (HP:0001141) | 4.11910691 |
| 3 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.10615446 |
| 4 | Stomatitis (HP:0010280) | 4.00036518 |
| 5 | Hypoplasia of the thymus (HP:0000778) | 3.93602051 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47977230 |
| 7 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.94155233 |
| 8 | Myositis (HP:0100614) | 2.93150917 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 2.87889300 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.87889300 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.87889300 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 2.83515571 |
| 13 | Abnormality of the prostate (HP:0008775) | 2.75220324 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 2.71481622 |
| 15 | Loss of speech (HP:0002371) | 2.71361690 |
| 16 | Abnormality of macular pigmentation (HP:0008002) | 2.67428422 |
| 17 | Stomach cancer (HP:0012126) | 2.64939723 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62097449 |
| 19 | Hypochromic anemia (HP:0001931) | 2.59314975 |
| 20 | T lymphocytopenia (HP:0005403) | 2.54464074 |
| 21 | Abnormal protein glycosylation (HP:0012346) | 2.53396123 |
| 22 | Abnormal glycosylation (HP:0012345) | 2.53396123 |
| 23 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.53396123 |
| 24 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.53396123 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 2.52207037 |
| 26 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.50448440 |
| 27 | Orchitis (HP:0100796) | 2.50100421 |
| 28 | Abnormality of eosinophils (HP:0001879) | 2.48900107 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.48546541 |
| 30 | Optic neuritis (HP:0100653) | 2.48546541 |
| 31 | Spontaneous hematomas (HP:0007420) | 2.47447354 |
| 32 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.46061724 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44826068 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.40096177 |
| 35 | Abnormality of T cell number (HP:0011839) | 2.39602586 |
| 36 | Polycythemia (HP:0001901) | 2.38655467 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.33034546 |
| 38 | Eosinophilia (HP:0001880) | 2.30064597 |
| 39 | Granulocytopenia (HP:0001913) | 2.27686884 |
| 40 | Severe combined immunodeficiency (HP:0004430) | 2.25591520 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 2.23616985 |
| 42 | Hematochezia (HP:0002573) | 2.23201684 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.20382191 |
| 44 | Obstructive lung disease (HP:0006536) | 2.20382191 |
| 45 | Amyotrophic lateral sclerosis (HP:0007354) | 2.17842721 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17261550 |
| 47 | Hypergonadotropic hypogonadism (HP:0000815) | 2.16784335 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.16057780 |
| 49 | Chest pain (HP:0100749) | 2.15382265 |
| 50 | Abnormality of T cells (HP:0002843) | 2.15342155 |
| 51 | Prolonged neonatal jaundice (HP:0006579) | 2.14991152 |
| 52 | Vasculitis (HP:0002633) | 2.14932708 |
| 53 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.12641436 |
| 54 | Thyroiditis (HP:0100646) | 2.12356199 |
| 55 | Abnormal biliary tract physiology (HP:0012439) | 2.11692594 |
| 56 | Bile duct proliferation (HP:0001408) | 2.11692594 |
| 57 | Albinism (HP:0001022) | 2.10996322 |
| 58 | Encephalitis (HP:0002383) | 2.09549302 |
| 59 | Cerebellar dysplasia (HP:0007033) | 2.08198450 |
| 60 | Leukocytosis (HP:0001974) | 2.06950227 |
| 61 | Thoracolumbar scoliosis (HP:0002944) | 2.05422952 |
| 62 | Episodic fever (HP:0001954) | 2.05182641 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.04202668 |
| 64 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.03248920 |
| 65 | Recurrent viral infections (HP:0004429) | 2.02916592 |
| 66 | Hip dysplasia (HP:0001385) | 2.02246659 |
| 67 | Alveolar cell carcinoma (HP:0006519) | 2.01275142 |
| 68 | Recurrent fungal infections (HP:0002841) | 1.99962069 |
| 69 | Microretrognathia (HP:0000308) | 1.97813050 |
| 70 | Acute lymphatic leukemia (HP:0006721) | 1.97547480 |
| 71 | Shoulder girdle muscle weakness (HP:0003547) | 1.97506731 |
| 72 | Chronic hepatic failure (HP:0100626) | 1.97417427 |
| 73 | Hypoplastic left heart (HP:0004383) | 1.96869944 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96329146 |
| 75 | Rimmed vacuoles (HP:0003805) | 1.92957857 |
| 76 | Progressive inability to walk (HP:0002505) | 1.91098383 |
| 77 | Embryonal renal neoplasm (HP:0011794) | 1.90958462 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89315494 |
| 79 | Glomerulopathy (HP:0100820) | 1.88625849 |
| 80 | Attenuation of retinal blood vessels (HP:0007843) | 1.88010381 |
| 81 | Lymphopenia (HP:0001888) | 1.86523009 |
| 82 | Opisthotonus (HP:0002179) | 1.86319618 |
| 83 | Pulmonary fibrosis (HP:0002206) | 1.85486714 |
| 84 | Brushfield spots (HP:0001088) | 1.84106490 |
| 85 | Abnormality of B cell number (HP:0010975) | 1.83748794 |
| 86 | Inflammation of the large intestine (HP:0002037) | 1.83596385 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 1.81329942 |
| 88 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.81246525 |
| 89 | Meningitis (HP:0001287) | 1.80695101 |
| 90 | Abnormality of macrophages (HP:0004311) | 1.80411688 |
| 91 | Recurrent sinusitis (HP:0011108) | 1.79578578 |
| 92 | Abnormal pupillary function (HP:0007686) | 1.78751244 |
| 93 | Delusions (HP:0000746) | 1.77909047 |
| 94 | Pelvic girdle muscle weakness (HP:0003749) | 1.76198008 |
| 95 | Tubulointerstitial nephritis (HP:0001970) | 1.75875286 |
| 96 | Recurrent skin infections (HP:0001581) | 1.74229826 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 1.73828487 |
| 98 | Cholecystitis (HP:0001082) | 1.73828487 |
| 99 | Combined immunodeficiency (HP:0005387) | 1.73420146 |
| 100 | Subaortic stenosis (HP:0001682) | 1.69940842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.12353842 |
| 2 | MAP4K1 | 3.28758994 |
| 3 | CAMKK2 | 3.07196196 |
| 4 | TESK2 | 2.83637571 |
| 5 | BLK | 2.79985399 |
| 6 | TYK2 | 2.47888020 |
| 7 | ZAK | 2.36679015 |
| 8 | TXK | 2.31792905 |
| 9 | STK16 | 2.20259451 |
| 10 | DYRK3 | 2.11704926 |
| 11 | MAP2K7 | 2.08916497 |
| 12 | MAP2K3 | 2.04614077 |
| 13 | MARK3 | 1.99931699 |
| 14 | GRK6 | 1.98133219 |
| 15 | PBK | 1.73217366 |
| 16 | SCYL2 | 1.69681177 |
| 17 | IKBKB | 1.69323925 |
| 18 | BMPR2 | 1.67789925 |
| 19 | MAP3K14 | 1.66467279 |
| 20 | KSR1 | 1.63392476 |
| 21 | IKBKE | 1.59377787 |
| 22 | NEK9 | 1.58603623 |
| 23 | ARAF | 1.58243919 |
| 24 | MAP3K9 | 1.55388453 |
| 25 | FRK | 1.55118570 |
| 26 | JAK3 | 1.53713965 |
| 27 | TBK1 | 1.48304428 |
| 28 | BCKDK | 1.47368108 |
| 29 | MAPK7 | 1.45710297 |
| 30 | BRD4 | 1.42686212 |
| 31 | ERN1 | 1.39339990 |
| 32 | IRAK3 | 1.19118926 |
| 33 | PRKD3 | 1.18340075 |
| 34 | TNK2 | 1.13122671 |
| 35 | CSNK1A1L | 1.12621919 |
| 36 | MAP2K2 | 1.10105045 |
| 37 | CSNK1G3 | 1.04921485 |
| 38 | BTK | 1.01309116 |
| 39 | ZAP70 | 1.01021611 |
| 40 | NUAK1 | 0.98617262 |
| 41 | TAF1 | 0.96877946 |
| 42 | NME1 | 0.94368818 |
| 43 | MAP3K5 | 0.93509722 |
| 44 | PIM1 | 0.92633879 |
| 45 | PDK1 | 0.89945856 |
| 46 | CAMK4 | 0.89859099 |
| 47 | RPS6KL1 | 0.86670408 |
| 48 | RPS6KC1 | 0.86670408 |
| 49 | TAOK2 | 0.84878757 |
| 50 | MAPK11 | 0.83375445 |
| 51 | PIK3CG | 0.82845634 |
| 52 | LYN | 0.81261303 |
| 53 | MATK | 0.80692306 |
| 54 | JAK1 | 0.79017174 |
| 55 | PKN1 | 0.78706702 |
| 56 | MUSK | 0.78695671 |
| 57 | GRK7 | 0.78211172 |
| 58 | BRSK2 | 0.74249941 |
| 59 | PRPF4B | 0.72504997 |
| 60 | RPS6KA6 | 0.72152505 |
| 61 | CSNK1G2 | 0.71463667 |
| 62 | MAPK13 | 0.70451909 |
| 63 | CSNK1G1 | 0.70310443 |
| 64 | AURKA | 0.69889551 |
| 65 | SMG1 | 0.69426232 |
| 66 | RPS6KA5 | 0.69011493 |
| 67 | KIT | 0.68005986 |
| 68 | STK11 | 0.67671924 |
| 69 | CSK | 0.67461141 |
| 70 | LCK | 0.67361802 |
| 71 | MAP3K4 | 0.66770824 |
| 72 | RPS6KA2 | 0.64466277 |
| 73 | MAP3K1 | 0.63908026 |
| 74 | PIM2 | 0.63468871 |
| 75 | HCK | 0.62319060 |
| 76 | RIPK4 | 0.62294675 |
| 77 | SYK | 0.62288532 |
| 78 | CCNB1 | 0.59718895 |
| 79 | STK38 | 0.59024954 |
| 80 | RPS6KA4 | 0.58817206 |
| 81 | ADRBK2 | 0.58579455 |
| 82 | CDK19 | 0.57497564 |
| 83 | CHUK | 0.55811230 |
| 84 | ICK | 0.55435436 |
| 85 | NEK6 | 0.53106098 |
| 86 | MAP3K13 | 0.52700568 |
| 87 | RAF1 | 0.52556497 |
| 88 | VRK2 | 0.51039735 |
| 89 | JAK2 | 0.49272899 |
| 90 | MAP3K11 | 0.48627384 |
| 91 | KSR2 | 0.48537764 |
| 92 | PRKD2 | 0.46250409 |
| 93 | VRK1 | 0.44950133 |
| 94 | DAPK1 | 0.44640626 |
| 95 | CSF1R | 0.44024152 |
| 96 | TLK1 | 0.42626554 |
| 97 | SGK3 | 0.41898793 |
| 98 | MAPK4 | 0.40879672 |
| 99 | MAP2K4 | 0.40854157 |
| 100 | MAP3K7 | 0.40835880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.69212706 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.69123677 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.52519792 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.49487652 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.09339594 |
| 6 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.05735858 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04838499 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.04271406 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.03523826 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.02941850 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.02410459 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.00060352 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.97230568 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89047446 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74977515 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.73619175 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66116949 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.63023198 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.60271937 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59367760 |
| 21 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.59359301 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.52875208 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51853894 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48898947 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48033005 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46061175 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40438511 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36023456 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35457677 |
| 30 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.34167262 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31887359 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.30478591 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25957205 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.22205031 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.19156848 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.18934728 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16514688 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16356197 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15959225 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.12930425 |
| 41 | Alcoholism_Homo sapiens_hsa05034 | 1.12785171 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10179259 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07879583 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06181022 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.02954797 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.00188036 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98691104 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94642584 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94335870 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91931331 |
| 51 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.90921122 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90437446 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89282877 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88960994 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.88571223 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88210659 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.87764738 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86930070 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86788524 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85537208 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84602913 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.83743123 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.82149244 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.81890781 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.79777239 |
| 66 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.79351028 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78832522 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77811776 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.77509183 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75570767 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75070482 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71393001 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70790679 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69653239 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.68284858 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67424719 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67145955 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66357741 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66211644 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.65867942 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61493848 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60901588 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60417147 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59569990 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57388171 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.57041862 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54505458 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52637120 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52383603 |
| 90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51403208 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51165548 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49034059 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.48722209 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48589885 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43851041 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43738703 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.43639730 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43573512 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40404106 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39785228 |

